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Abstract
Background:  The  aim  of  the  study  is  to  compare  the  efﬁcacy  of  levobupivacaine  induced  con-
tinuous spinal  anesthesia  (CSA)  versus  single  dose  spinal  anesthesia  (SDSA)  in  patients  who  are
planned  to  undergo  transurethral  prostate  resection.
Methods:  Sixty  years  or  older,  ASA  I--II  or  III,  50  patients  were  included  in  the  study.  12.5  mg
0.5% levobupivacaine  were  administered  intrathecally  in  SDSA  group.  In  CSA  group,  initially
2  mL  of  0.25%  levobupivacaine  were  administered  through  spinal  catheter.  In  order  to  achieve
sensory  block  level  at  T10  dermatome,  additional  1  mL  of  0.25%  levobupivacaine  were  adminis-
tered  through  the  catheter  in  every  10  min.  Hemodynamic  parameters  and  block  characteristics
were  recorded.  Preoperative  and  postoperative  blood  samples  of  the  patients  were  drawn  to
determine  plasma  cortisone  and  plasma  epinephrine  levels.
Results:  CSA  technique  provided  better  hemodynamic  stability  compared  to  SDSA  technique
particularly 90  min  after  intrathecal  administration.  The  rise  in  sensory  block  level  was  rapid  and
the  time  to  reach  surgical  anesthesia  was  shorter  in  SDSA  group.  Motor  block  developed  faster  in
SDSA  group.  In  CSA  group,  similar  anesthesia  level  was  achieved  by  using  lower  levobupivacaine
dose  and  which  was  related  to  faster  recovery.  Although,  both  techniques  were  effective  in
preventing  surgical  stress  respond,  postoperative  cortisone  levels  were  suppressed  more  in
SDSA  group.
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Conclusion:  CSA  technique  with  0.25%  levobupivacaine  can  be  used  as  a  regional  anesthesia
method for  elderly  patients  planned  to  have  TUR-P  operation.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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nesthesia  is  applied  in  10--20%  of  urologic  interventions.
nesthetic methods  chosen  within  general  principles  are
opical, regional  and  general.1,2 Most  patients  with  bladder
bstruction caused  by  benign  prostatic  hyperplasia  are  suc-
essfully  treated  by  transurethral  resection  of  the  prostate
TUR-P).3 TUR-P  is  often  performed  on  older  patients  with
mpaired renal  function,  cardiovascular  and  respiratory
roblems. Research  has  found  many  side  effects  of  TUR-P
ncluding bleeding,  transurethral  resection  syndrome  (TUR),
ladder  perforation,  hypothermia,  intraoperative  and  early
ostoperative occurrence  of  disseminated  intravascular
oagulation, with  high  reported  morbidity  rates.  To  mini-
ize hemodynamic  changes  in  these  patients  it  is  important
o provide  stable  anesthesia.  General  anesthesia  may  make
dentiﬁcation of  complications  such  as  TUR  syndrome  and
ladder perforation  difﬁcult,  so  regional  anesthesia  is  the
referred method  in  suitable  TUR-P  cases.4--7
Single-dose  spinal  anesthesia  (SDSA)  is  widely  used  in
hese interventions  though  it  has  the  disadvantage  of  not
roviding the  required  duration  in  operations  that  run  longer
han expected.  With  the  continuous  spinal  anesthesia  (CSA)
echnique, local  anesthetic  dose  can  repeated,  thus  making
t possible  to  use  this  spinal  anesthesia  method  in  operations
ith long  duration.8--12 Another  advantage  of  CSA  is  that  it
nables to  titrate  the  dose  of  local  anesthetic  thus  allow-
ng better  control  of  sensory  and  motor  block  level,  no  risk
f local  anesthetic  toxicity  and  providing  shorter  recovery
eriods. Compared  to  SDSA,  its  most  important  advantage
s that  it  provides  perfect  hemodynamic  stability.  Further-
ore, spinal  catheter  may  be  inserted  in  regional  anesthesia
reparation room  before  the  operation,  thus  preventing  loss
f time  between  operations.10,13,14
Levobupivacaine,  a  bupivacaine  S  isomer  commonly  used
n spinal  anesthesia  (SA),  has  less  side  effects  on  the
ardiovascular (CVS)  and  central  nervous  systems  (CNS)
han bupivacaine  with  similar  effective  onset  time  and
uration.7,15--17 Although  levobupivacaine  use  in  various
egional anesthesia  techniques  have  been  reported  previ-
usly, description  of  its  use  in  CSA  is  limited.  We  have
ypothesized that  levobupivacaine  provides  better  hemody-
amic stability  when  used  in  CSA  compared  to  SDSA.  In  order
o test  this  hypothesis,  patients  scheduled  to  have  TUR-P
peration were  administered  either  SDSA  or  CSA  with  lev-
bupivacaine; hemodynamics,  sensory-motor  block  levels,
nesthetic quality  and  complications  were  compared.aterials and methods
fter  receiving  permission  from  Bulent  Ecevit  University
edical Faculty  Hospital  Ethics  Committee  (06.12.2007,
p
s
eecision  no.  2007/09/17),  this  research  was  carried  out  in
he Department  of  Anesthesiology  and  Reanimation  between
ecember 2007  and  June  2008.  Fifty  patients  over  the  age
f 60  scheduled  to  have  elective  TUR-P  interventions  at  ASA
--III risk  groups  were  included  in  the  study  after  reading  the
nformed consent  form.  The  patients  were  randomized  into
ither continuous  spinal  anesthesia  group  (Group  CSA,  n:25)
r single-dose  spinal  anesthesia  group  (Group  SDSA,  n:25)  by
andomized numbers  table.
Exclusion  criteria  were  refusing  to  be  included  in  the
tudy, allergies  to  the  research  drugs,  severe  cardiac  failure
unstable coronary  artery  disease,  2nd  and  3rd  degree  heart
lock, congestive  heart  failure,  ventricular  tachyarrhyth-
ia) and  valvular  heart  disease  (serious  aortic  stenosis),
oagulation abnormalities,  low  molecular  weight  heparin
dministration in  the  previous  12  h,  intake  of  non-steroidal
nti-inﬂammatory drug  within  the  24  h,  history  of  alcohol  or
rug addiction,  presence  of  neurologic  disorders  or  psychi-
tric disease.
All the  patients  were  premedicated  with  0.03  mg/kg
idozolam (Dormicum®) intramuscularly  30  min  prior  to
heir arrival  to  operation  theater.  Patients  were  taken  to
he preoperative  preparation  unit  and  were  monitored  (non-
nvasive blood  pressure,  heart  rate  and  peripheral  oxygen
aturation while  breathing  room  air)  these  values  were
ecorded as  control  values.  Patients  were  given  4  l/min
xygen through  a  mask,  a 20  G  cannula  was  inserted  for
ntravenous access  and  10  mL/kg  0.09%  saline  was  infused
ithin 30  min,  afterwards  the  rate  was  set  at  5  mL  kg/h.
lood samples  taken  from  each  patient  while  opening  the
ein was  centrifuged  to  separated  plasma  from  serum  and
tored in  a freezer  at  −20 ◦C.
All patients  had  lumbar  puncture  under  aseptic  condi-
ions, while  sitting,  between  L3--4  or  L  2--3  according  to
nesthesist’s preference.  The  lumbar  puncture  level  was
ecorded. Skin  and  subcutaneous  2  mL  2%  lidocaine  (Aritmal®
 mL  ampoule)  inﬁltration  anesthesia  was  given  with  a  22  G
eedle. Anesthesia  was  begun  for  Group  CSA  with  2  mL  0.25%
evobupivacaine after  a  22  G  spinal  catheter  (Spinocath®)
as placed  2--3  cm  into  the  intrathecal  interval.  After  the
0th min  if  the  level  of  sensory  block  had  not  reached  T10,
n extra  1  mL  0.25%  levobupivacaine  was  given  through  the
atheter, this  was  repeated  at  10  min  intervals  until  T10
lock level  was  reached.  The  total  dose  of  levobupivacaine
as recorded.
Spinal anesthesia  was  induced  in  group  SDSA  patients
ith 12.5  mg  (2.5  mL)  0.5%  levobupivacaine  injected  into  the
ntrathecal interval  with  a  22  G  Quinke  needle.After the  injection  blood  pressure,  heart  rate,  SpO2,  pin-
rick test  for  sensory  block  level,  and  modiﬁed  Bromage
cale (MBS)  were  used  to  evaluate  degree  of  motor  block
very 2.5  min  up  to  the  15th  min  and  every  5  min  between
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Table  1  Demographic  data  (mean  ±  SD).
Group  Group  CSA
(n =  25)
Group  SDSA
(n =  25)
p
Age  (year)  71.04  ±  6.62  70.68  ±  5.68  0.838
Weight (kg)  79.6  ±  11.39  80.24  ±  11.06  0.841
Operation time
(min)
50.00 ±  7.79  51.44  ±  8.78  0.543
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15  and  45  min.  (MBS:  0  no  paralysis,  patient  can  fully  ﬂex  foot
and knee;  1  Can  only  move  knee  and  foot,  cannot  lift  straight
leg; 2  cannot  bend  knee,  can  only  move  foot;  3  full  paraly-
sis.) After  45  min  the  patients  were  taken  to  the  operating
room.
In both  groups  the  time  from  the  injection  to  sensory
block level  reaching  dermatome  T10  was  recorded  as  the
surgical anesthetic  duration.  It  was  planned  that  patients
who reached  dermatome  T10  and  above  sensory  block  level
gave permission  for  the  operation.  After  spinal  injection
until MBS  1  was  reached  was  denoted  the  motor  block  ini-
tiation time.  From  the  injection  to  peak  dermatome  that
is sensory  block  level  reached  maximum  dermatome,  was
called the  peak  dermatome  time.  From  the  start  of  the
surgical procedure  to  the  end  was  the  operation  duration.
Sensory  block  level  was  checked  using  the  pin-prick  test
(needle prick).  Sensory  block  level  was  assumed  to  have
reached the  dermatome  when  the  patient  no  longer  felt  the
needle prick.
When mean  arterial  blood  pressure  (MAP)  decreased  20%
from the  basal  level  hypotension  was  diagnosed  and  5  mg
ephedrine HCL  (Osel  drugs)  was  administered.  Heart  rate
below 50  beats  per  min  was  accepted  as  bradycardia  and
0.5 mg  atropine  (atropine  1  mL  amp,  Drogsan)  was  adminis-
tered. Total  liquids  given  to  the  patient,  as  well  as  ephedrine
and atropine  doses  were  recorded.
Patients  taken  to  the  operating  theater  were  monitored
using an  ADU  anesthetic  monitor  (Datex-Ohmeda® S/5  Anes-
thetic Monitor)  for  5-lead  surface  electrocardiogram  (ECG,
DII), SpO2 and  non-invasive  arterial  blood  pressure.
After  the  operation  ﬁnished  the  CSA  group  had  the
catheter removed.  Both  groups  were  given  a  PCA  unit
(Abbot Pain  Management  Provider)  with  iv  morphine  (bolus
dose: 2  mg,  lock-out  time  30  min)  for  postoperative  analge-
sia. From  intrathecal  injection  to  ﬁrst  use  of  the  PCA  was
recorded as  the  ﬁrst  analgesic  duration.
Following  intrathecal  injection  all  patients  were  moni-
tored at  50,  60,  70,  80,  90,  100,  110,  120,  150,  180  min
and 4,  6,  9,  12,  15,  18  and  24  h.  Values  for  blood
pressure, heart  rate,  SpO2,  VRS  (verbal  pain  evaluation
scoring), sensory  block  level,  MBS  score,  PCA  machine
requests (Dem),  number  of  times  drugs  were  adminis-
tered by  PCA  (Del)  and  total  morphine  given  by  PCA  were
recorded.
Degree of  pain  was  evaluated  using  VRS  (0:  no  pain;  1
slight pain;  2  moderate  pain;  3  severe  pain;  4  very  severe
pain; 5  unbearable  pain).  From  peak  dermatome  sensory
block until  it  regressed  two  levels  was  recorded  as  the  sec-
ond dermatome  reduction  duration.  From  spinal  injection
to MBS  score  of  0  was  recorded  as  Bromage  scale  0  dura-
tion. Eight  hours  after  the  operation  blood  samples  from  all
patients were  centrifuged  to  separate  serum  from  plasma
and stored  in  a  freezer  at  −20 ◦C.  At  the  end  of  the  research
serum cortisol  and  plasma  adrenaline  levels  in  preoperative
and postoperative  blood  samples  were  measured  using  the
ELISA method.Statistical  analysis
SPSS  11.5  program  was  used  for  statistical  analysis  of  data.
The data  was  analyzed  for  normal  distribution  using  the
t
t
(ASA (I/II/III) 3/13/9  2/15/8  0.818
olmogorov  Smirnoff  test.  The  Mann  Whitney  U  test  was
sed to  compare  the  following  continuous  data  from  the  two
roups: operation  duration,  height,  weight,  age,  blood  pres-
ure, heart  rate,  sensory  block  level,  highest  sensory  block
evel, sensory  block  dermatome  T10  time,  sensory  block
wo segment  regression  time,  MBS,  VRS,  time  of  ﬁrst  anal-
esic dose,  total  analgesic  use,  PCA  requests  and  number
f times  drugs  were  administered  by  PCA  Del/Dem  values,
otal atropine  and  ephedrine  use,  and  cortisol  and  adrenalin
evels. To  analyze  the  repetition  of  these  data  within  the
roups the  Wilcoxon  test  was  used.  The  chi-square  test
as used  to  analyze  frequency  (%)  results  of  ASA  physi-
al classiﬁcation,  lumbar  puncture  level,  nausea-vomiting
nd side  effects.  Descriptive  statistics  for  the  data  such  as
ean and  standard  deviation  (mean  ±  SD),  mode  and  fre-
uency (number  and  %)  were  determined.  Graphs  of  the
hanges in  difference  between  the  groups  against  time  were
onstructed. A  value  of  p  <  0.05  was  accepted  as  signiﬁ-
ant.
esults
he  study  comprised  a  total  of  50  patients  in  2  groups,  all
atients completed  the  protocol.
emographic  data
here  were  no  statistically  signiﬁcant  differences  between
he two  groups  in  terms  of  age,  body  weight,  height,  ASA
isk class  and  operation  duration  (Table  1).
emodynamic  changes
omparing  the  groups  blood  pressure  in  the  90,  100,  120,
50, 180  min  and  4,  6,  9,  12,  15,  18  and  24  h  after  intrathecal
njection the  CSA  group  was  signiﬁcantly  higher  than  the
DSA group  (p  <  0.05)  (Fig.  1).
Within  the  CSA  group  blood  pressure  in  the  2.5,  5,  7.5,  10,
2.5, 15,  20,  25  and  30  min  after  intrathecal  injection  was
igniﬁcantly lower  than  the  control  values  (p  <  0.05)  (Fig.  1).
Within  the  SDSA  group  when  blood  pressure  changes  were
xamined they  were  found  to  be  signiﬁcantly  lower  than  the
ontrol values  at  all  times  (p  <  0.05)  (Fig.  1).
There was  no  statistical  difference  between  heart  rate  in
he two  groups  at  any  measurement  time  (p  >  0.05)  (Fig.  2).Within  each  group  heart  rate  was  signiﬁcantly  lower
han control  values  at  all  times  after  intrathecal  injection
p <  0.05)  (Fig.  2).
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Figure  1  Changes  in  mean  arterial  blood  pressure  (MAP).  *p  <  0.05  (between  Group  CSA  and  Group  SDSA). †p  <  0.05  (signiﬁcant
difference compared  with  Group  CSA  control  values). ‡p  <  0.05  (signiﬁcant  difference  compared  with  Group  SDSA  control  values).
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Sigure  2  Changes  in  heart  rate  (HR). †p  <  0.05  (signiﬁcant  dif
ant  difference  compared  with  Group  SDSA  control  values).
nesthetic  properties
umbar  puncture  was  performed  at  L2--L3  interval  in  8  and
t L3--L4  interval  in  17  patients  in  the  CSA  group;  6  patients
ad lumbar  puncture  at  L2--L3  interval  and  19  patients  at
3--L4 interval  in  the  SDSA  group.  There  was  no  statistically
igniﬁcant difference  in  lumbar  puncture  level  between  the
wo groups  (p  >  0.05).Comparing  the  groups  modiﬁed  Bromage  scores  (MBS)
rom 5  to  120  min  values  were  signiﬁcantly  higher  in  group
DSA than  in  group  CSA  (p  <  0.05)  (Fig.  3).
t
tce  compared  with  Group  CSA  control  values). ‡p  <  0.05  (signiﬁ-
Comparing  the  groups  sensory  block  levels  at  2.5,  5,  7.5,
0, 12.5,  15,  20,  25,  30  and  35  min  after  intrathecal  injection
he SDSA  group  values  were  signiﬁcantly  higher  than  the  CSA
roup (p  >  0.05)  (Fig.  4).
No  statistically  signiﬁcant  difference  was  found  between
RS scores  for  the  groups  (p  >  0.05).  Average  peak  der-
atome values  were  T8  for  the  CSA  group  and  T7  for  the
DSA group.  There  was  no  signiﬁcant  difference  between
he two  groups  peak  dermatome  values  (p  >  0.05).
Comparing the  groups  block  times  average  peak  dura-
ion, surgical  anesthetic  duration,  and  motor  block  start
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Figure  3  MBS  changes  in  the  groups.  *p  <  0.05  (between  Group  CSA  and  Group  SDSA).
Table  2  Block  Times  (min)  (mean  ±  SD).
Block  times  Group  CSA  (n  =  25)  Group  SDSA  (n  =  25)  p
Time  to  reach  peak  dermatome  31.64  ±  11.94  25.10  ±  5.89  0.019*
Two  segment  regression  time  79.28  ±  18.66  90.08  ±  14.66  0.030*
Surgical  operation  time  18.56  ±  6.31  13.08  ±  4.34  0.010*
Motor  block  start  time  13.04  ±  7.10  6.04  ±  2.30  0.000*
Time  to  reach  MBS  0  170.28  ±  51.32  186.04  ±  35.13  0.211
First  analgesic  time  268.88  ±  94.52  253.60  ±  92.46  0.566* p < 0.05 (between Group CSA and Group SDSA).time  in  the  SDSA  group  was  signiﬁcantly  shorter  than  in  the
CSA group.  At  the  same  time  the  two  segment  regression
time was  signiﬁcantly  longer  in  group  SDSA  than  in  group
CSA (p  <  0.05)  (Table  2).  No  signiﬁcant  difference  was  found
b
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Figure  4  Sensory  level  changes  in  the  groups.  *petween  the  two  groups  MBS  0  and  ﬁrst  use  of  analgesia
imes (p  >  0.05)  (Table  2).
Group  SDSA  used  a  signiﬁcantly  higher  dose  of  levobupi-
acaine than  group  CSA  (p  <  0.05).  There  was  no  statistically
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Table  3  Total  drugs  and  liquids  given  (mean  ±  SD).
Totals  Group  CSA  (n  =  25)  Group  SDSA  (n  =  25)  p
Total  levobupivacaine  8.70  ±  1.63  12.50  ±  0.00  0.000*
Total  morphine  8.00  ±  3.78  6.96  ±  2.83  0.278
Total  ephedrine  0.20  ±  1.00  1.20  ±  3.31  0.160
Total  atropine  0.02  ±  0.1  0.04  ±  0.13  0.561
Total  liquids  1290.20  ±  180.01  1337.60  ±  148.86  0.315
* p < 0.05 (between Group CSA and Group SDSA).
Table  4  Preoperative  and  postoperative  adrenalin  and  cortisol  levels  (mean  ±  SD).
Group  Group  CSA  (n  =  22)  Group  SDSA  (n  =  22)  p
Preop  Adrenalin  249.90  ±  62.63  265.40  ±  70.90  0.446
Postop  Adrenalin  190.04  ±  52.63† 180.76  ±  54.77‡ 0.570
Preop  Cortisol  168.95  ±  85.51  134.22  ±  51.07  0.111
Postop  Cortisol 127.51  ±  57.10† 89.37  ±  32.98‡,* 0.010
* p < 0.05 (between Group CSA and Group SDSA).
† p < 0.05 (signiﬁcant difference compared with Group CSA control values).
‡ p < 0.05 (signiﬁcant difference compared with Group SDSA control values).
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Comparing side  effects  in  both  groups,  while  there  was  no
difference between  the  groups  in  terms  of  nausea,  vomiting,
respiratory depression,  headache  and  rash,  lower  back  pain
in group  CSA  was  signiﬁcantly  greater  than  in  group  SDSA
(p <  0.05)  (Table  5).
Table  5  Side  effects  (n,  %).
Group  Group  CSA
(n =  25)
Group  SDSA
(n =  25)
p
Nausea:  0  2  (8%)  0.153
Vomiting:  0  0  1.000
Respiratory  depression:  0  0  1.000
Headache:  0  1  (4%)  0.317Figure  5  Average  number  of  requests  from  the  PC
igniﬁcant  difference  between  the  two  groups  average  con-
umption of  morphine,  ephedrine,  atropine  and  liquids
p > 0.05)  (Table  3).
No  difference  was  found  in  the  number  of  doses  given
y the  two  groups  PCA  machines  (p  >  0.05).  Comparing  the
umber of  requests  to  the  PCA  machines  at  9,  18  and  24  h
he CSA  group  requests  were  signiﬁcantly  higher  than  the
DSA group  (p  <  0.05)  (Fig.  5).
No  signiﬁcant  difference  was  found  between  the  two
roups plasma  adrenaline  levels  (p  >  0.05)  (Table  4).
Within each  group  postoperative  plasma  adrenalin  levels
ere signiﬁcantly  lower  than  the  preoperative  control  levels
p < 0.05)  (Table  4).
Comparing  the  groups’  postoperative  serum  cortisol  lev-
ls, the  SDSA  group  levels  were  signiﬁcantly  lower  than  the
SA group  levels  (p  <  0.05)  (Table  4).
Within  both  groups  postoperative  serum  cortisol  levels
ere signiﬁcantly  lower  than  preoperative  control  levels
p < 0.05)  (Table  4).
Lower  back  pain:  9  (36%)  2  (8%)  0.018*
Rash:  0  0  1.000
* p < 0.05 (between Group CSA and Group SDSA).
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Discussion
This  study  compared  continuous  spinal  anesthesia  with
single-dose spinal  anesthesia  using  levobupivacaine  in
geriatric patients  undergoing  transurethral  urologic  inter-
ventions. We  found  that  continuous  spinal  anesthesia
provided better  hemodynamic  stability,  shorter  recovery
periods and  equal  anesthetic  quality.
In  older  patients  increases  in  health  problems  combined
with suppressed  physiologic  compensatory  mechanisms
means that  hemodynamic  instability  linked  to  spinal  anes-
thesia may  be  more  serious  and  last  longer.  Rapid  spread
of sympathetic  block  in  spinal  anesthesia  may  cause  an
increase in  morbidity,  especially  in  older  patients  with
reduced cardiovascular  adaptation  mechanisms.18 One  of
the most  important  factors  to  be  aware  of  in  patients  of
increased age  and  with  accompanying  diseases  is  hemo-
dynamic stability.  In  a  prospective  study  on  cardiac  arrest
linked to  anesthesia  Biboulet  et  al.19 determined  the  most
important factors  in  cardiac  arrest  in  patients  over  84  and
with an  ASA  risk  factor  of  3  and  above.  They  found  inap-
propriate anesthetic  doses,  hypovolemia  and  hypoxia  due
to difﬁculty  keeping  the  airway  open  were  the  most  com-
mon reasons  for  cardiac  arrest.  Especially  in  patients  who
are older,  or  have  cardiovascular  and  respiratory  system
problems, even  low  doses  may  result  in  greater  anesthetic
levels, so  techniques  such  as  CSA  which  allow  the  possibility
of dose  titration  should  be  given  preference  compared  to
SDSA.20
Favarel  et  al.,21 in  a  study  comparing  CSA  and  SDSA  use
of 0.5%  hyperbaric  bupivacaine,  showed  that  blood  pres-
sure lowered  less  in  the  CSA  group  compared  to  the  SDSA
group. The  researchers  found  that  the  CSA  group  had  less
hemodynamic changes  and  that  the  slower  start  of  segmen-
tal block  and  slow  development  of  sympathetic  block  made
adaptation easier.21 De  Andres  et  al.22 used  0.5%  isobaric
bupivacaine in  their  comparison  of  CSA  and  SDSA  and  found
hypotension due  to  the  repeated  dose  in  the  CSA  group  did
not need  vasopressor  drugs  while  the  incidence  of  hypoten-
sion in  the  SDSA  group  was  greater.
Klimscha  et  al.18 compared  0.5%  isobaric  bupivacaine  in
CSA, SDSA  and  epidural  anesthesia.  Blood  pressure  in  the
CSA group  did  not  reduce,  in  continuous  epidural  anesthe-
sia there  was  a  15  ±  3%  reduction  and  a  19  ±  2%  decrease
in the  SDSA  group.  A  comparison  of  SDSA  with  CSA  by  Reisli
et al.23 found  a  signiﬁcant  reduction  in  blood  pressure  in  the
SDSA group  compared  to  the  CSA  group.  Labaille  et  al.24 used
low dose  0.125%  isobaric  bupivacaine  with  CSA  technique
to provide  effective  anesthesia  with  minimal  hemodynamic
changes in  older  patients.  Minville  et  al.25 compared  SDSA
and CSA  with  low  dose  bupivacaine  in  planned  hip  opera-
tions in  patients  over  75  years.  Occurrence  of  hypotension
in the  CSA  group  was  31%  and  68%  in  the  SDSA  group;  seri-
ous hypotension  was  8%  in  the  CSA  group  and  51%  in  the
SDSA group.  In  the  CSA  group  4.5  ±  2  mg  ephedrine  was
consumed, compared  with  11  ±  2  mg  in  the  SDSA  group.
They found  the  CSA  group  was  hemodynamically  more  sta-
ble.
However Pitkanen  et  al.26 compared  CSA  and  SDSA  tech-
niques in  planned  hip  and  knee  operations  in  40  patients  and
found no  signiﬁcant  difference  in  hemodynamic  stability  of
the groups.
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This  study  found  both  groups  had  lower  blood  pressure
han the  control  values.  In  the  CSA  group  4%  of  patients
eveloped hypotension  compared  to  12%  in  the  SDSA  group,
ubsequently the  dose  of  ephedrine  used  was  lower  in  the
SA group.  The  lower  blood  pressure  in  the  SDSA  group  com-
ared to  the  CSA  group  is  similar  to  results  from  previous
tudies. Results  from  the  use  of  levobupivacaine  for  CSA
howed that  it  provides  more  hemodynamic  stability  than
upivacaine in  CSA,  in  agreement  with  previously  published
esearch.
Patients under  spinal  anesthesia  show  a  reduction  in
eart rate  due  to  preganglion  ﬁber  blockage  and  a  reduc-
ion in  left  atrium  pressure.8 Shenkman  et  al.27 used  low
oses of  local  anesthetic  with  the  CSA  technique  to  provide
ood control  of  hemodynamics  and  this  advantage  over  the
DSA technique  made  it  suitable  for  use  in  older  and  more
igh risk  patients.  They  found  a  maximum  reduction  in  heart
ate of  7.2%  using  0.1%  bupivacaine  for  CSA  in  ASA  III--IV  risk
roup patients.  The  researchers  found  that  using  CSA  they
ould modify  the  sensory  block  level  in  a  controlled  fashion
nd reduce  the  risk  of  hemodynamic  instability.27 Favarel
t al.21 found  no  signiﬁcant  difference  in  heart  rate  using
yperbaric bupivacaine  for  CSA  and  SDSA.  Similar  research
nding no  signiﬁcant  difference  in  heart  rate  when  using  CSA
ompared to  SDSA  is  available.18,25,28 This  study  found  no  sig-
iﬁcant difference  in  heart  rate  between  the  CSA  and  SDSA
roups at  any  time  interval,  similar  to  the  literature.
Research  evaluating  CSA  using  levobupivacaine  are
imited. The  only  research  in  literature  by  Sell  et  al.14
ound  the  minimum  effective  dose  of  local  anesthetic  was
1.7 mg  using  levobupivacaine  for  CSA  in  hip  replacement
perations. Our  study  found  an  average  dose  of  8.7  mg  lev-
bupivacaine provided  sufﬁcient  anesthesia.  We  are  of  the
pinion that  the  difference  may  be  due  to  demographics,
osition, intended  block  level  and  other  such  factors.
This  study  found  the  time  to  reach  dermatome  T10
ensory block  level  was  signiﬁcantly  longer  in  the  CSA
roup than  the  SDSA  group.  This  is  similar  to  times  to
each sensory  block  levels  that  allow  surgery  in  previous
esearch.21,22,29 While  there  was  no  signiﬁcant  difference  in
eak dermatome,  the  time  for  the  CSA  group  to  reach  peak
ermatome was  signiﬁcantly  longer.  This  result  conforms
ith previous  studies.18,28
Comparing  Bromage  scale  evaluations  of  motor  block
evel the  CSA  group  was  signiﬁcantly  lower  than  the  SDSA
roup. While  motor  block  is  a  desirable  characteristic  in
urgeries such  as  orthopedics,  it  delays  neurologic  evalu-
tion postoperatively  and  obstructs  mobilization.  For  this
eason an  early  end  to  motor  block  is  a  desirable  property.
he lower  degree  of,  and  early  end  to,  motor  block  in  the
SA group  could  be  seen  as  an  advantage.
SDSA  group  patients  required  an  average  of  12.5  mg  lev-
bupivacaine compared  to  8.7  mg  for  the  CSA  group.  Though
he CSA  group  used  less  local  anesthetic,  sufﬁcient  anes-
hetic level,  similar  to  the  SDSA  group,  was  achieved.
No  signiﬁcant  difference  was  found  between  the  groups
n terms  of  pain  levels  evaluated  using  VRS.  While  there  was
o difference  in  the  two  groups’  use  of  morphine  and  num-
er of  time  drugs  were  given  by  the  PCA  unit,  there  were
igniﬁcantly more  requests  from  the  PCA  units  by  the  CSA
roup 9,  18  and  24  h  after  the  operation.  We  believe  this
ay be  due  to  greater  complaints  of  back  pain  by  the  CSA
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26  
roup  compared  to  the  SDSA  group.  It  may  also  be  due  to
he lower  local  anesthetic  dose  and  lower  nerve  block  level
n the  CSA  group.
It  is  known  that  epidural  and  spinal  anesthesia  at  dif-
erent levels  suppresses  the  neuroendocrine  stress  response
etter than  general  anesthetic.  High  level  spinal  block  is
ecessary to  suppress  the  andrenergic  response.30 Seitz
t al.31 found  cortisol  increased  during  surgery  in  lower
xtremity operations  using  general  anesthetic,  while  the
pidural anesthetic  group  had  lower  levels  compared  to  val-
es from  before  surgery.  Pfug  et  al.32 found  higher  levels  of
drenalin postoperatively  compared  to  control  values.  Low
evel  spinal  anesthesia  prevents  this  increase,  the  high  level
pinal anesthetic  group  had  values  lower  than  the  controls.
hile Moller  et  al.33 found  no  difference  in  cortisol  levels  in
he late  postoperative  period  comparing  spinal  and  general
nesthesia, during  surgery  and  in  the  early  postoperative
eriod cortisol  levels  were  lower  in  the  spinal  anesthesia
roup. Comparing  the  postoperative  plasma  adrenalin  and
erum cortisol  levels  in  both  groups  in  this  study,  both  groups
ad lower  levels  compared  to  control  values.  The  SDSA
roup postoperative  serum  cortisol  levels  were  signiﬁcantly
ower. The  higher  nerve  block  level  in  the  SDSA  group  may
e responsible  for  greater  suppression  of  afferent  neural
mpulses originating  in  the  splanchnic  sympathetic  nerves.
In  conclusion  continuous  spinal  anesthesia  using  0.25%
oncentration levobupivacaine  to  provide  regional  anesthe-
ia for  transurethral  prostate  resection  operations  in  older
atients can  be  used  safely.
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